Common Sense Oncology: Equity, Value, and Outcomes That Matter

Brooke E. Wilson, Manju Sengar, Michelle Tregear, Winette van der Graaf, Nicolò Matteo Luca Battisti, Degi Laszlo Csaba, Enrique Soto-Perez-de-Celis, Bishal Gyawali, Christopher M. Booth*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

While some recent drug treatments have been transformative for patients with cancer, many treatments offer small benefits despite high clinical toxicity, time toxicity and financial toxicity. Moreover, treatments that do provide substantial clinical benefits are not available to many patients globally due to issues with availability and affordability. The Common Sense Oncology's vision is that patients will have access to treatments that provide meaningful improvements in outcomes that matter, regardless of where they live. In recognition of the growing challenges in the field of oncology, Common Sense Oncology seeks to achieve this vision by improving evidence generation, evidence interpretation and evidence communication.
Original languageEnglish
Article numbere100039
JournalAmerican Society of Clinical Oncology Educational Book
Volume44
Issue number3
DOIs
Publication statusPublished - Jun 2024

Bibliographical note

© 2024 by American Society of Clinical Oncology

Fingerprint

Dive into the research topics of 'Common Sense Oncology: Equity, Value, and Outcomes That Matter'. Together they form a unique fingerprint.

Cite this